/
 Application of the Data:  Application of the Data:

Application of the Data: - PowerPoint Presentation

giovanna-bartolotta
giovanna-bartolotta . @giovanna-bartolotta
Follow
345 views
Uploaded On 2020-04-06

Application of the Data: - PPT Presentation

Cardiometabolic Disease Is an Epidemic Clinical Diagnosis of Metabolic Syndrome Adiposity Insulin Resistance Inflammation and Oxidative Stress Whats the Correlation Typical Characteristics of the Patient With MetSyn ID: 776059

risk statin patient abbreviations risk statin patient abbreviations cont hiv factors placebo therapy drug management pitavastatin metsyn sams infection

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document " Application of the Data:" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Application of the Data:

Slide2

Slide3

Cardiometabolic Disease Is an Epidemic

Slide4

Clinical Diagnosis of Metabolic Syndrome

Slide5

Adiposity, Insulin Resistance, Inflammation and Oxidative Stress - What's the Correlation?

Slide6

Typical Characteristics of the Patient With MetSyn

Slide7

Risk-Enhancing Factors for CVD2018 ACC/AHA Guidelines

Slide8

Treating the Risk Factors

Slide9

Treating the Risk Factors (cont)

Slide10

Outcomes Data of CV Risk Reduction With Guideline-Indicated Therapies

Slide11

Aspirin Use for the Prevention of CVD 

Slide12

Patient With MetSyn With Multiple Comorbidities

Slide13

Who Should Be on Statin Therapy?

Slide14

Team Clinician-Patient Discussion

Slide15

Pearls in Management of SAMS

Slide16

Typical Patient With Known CAD & SAMS

Slide17

REDUCE-ITIcosapent Ethyl (EPA) vs Placebo

Slide18

Lifestyle Management

Slide19

Pitavastatin Meta-AnalysisNODM vs Placebo or Statin Control

Slide20

Effects of Nonstatin Therapy on DM

Slide21

Icosapent Ethyl Label

Slide22

Risk of Developing NODMMeta-Analysis of Placebo-Controlled Statin Trials

Slide23

Predisposing Factors for NODM

Slide24

Muscle AE Terminology and Tips

Slide25

Reasons for Increased ASCVD Risk in HIV Infection

Slide26

Copenhagen Comorbidity in HIV Infection Study

Slide27

Statin Therapy Considerations in Individuals Infected With HIV

Slide28

Lifestyle Management Recommendations2019 AACE/ACE Consensus Statement

Slide29

Common Drug Classes That May Interact With Statins

Slide30

Drug-Drug InteractionsUse of Statins With Protease Inhibitors

Slide31

Team-Based Multidisciplinary Approach

Slide32

INTREPIDPitavastatin vs Pravastatin in ART-Treated, HIV-1-Infected Individuals With Dyslipidemia

Slide33

REPRIEVE Trial Design With Pitavastatin

Slide34

Conclusions

Slide35

Abbreviations

Slide36

Abbreviations (cont)

Slide37

Abbreviations (cont)

Slide38

Abbreviations (cont)